Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Rodriguez-Roisin

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
American Journal of Respiratory and Critical Care Medicine|January 7, 2016
Network Analysis of Lung Transcriptomics Reveals a Distinct B-Cell Signature in EmphysemaRosa Faner, Tamara Cruz, Teresa Casserras, et al.
Respiratory Medicine|November 18, 2005
Proposal for a multidimensional staging system for chronic obstructive pulmonary diseaseBartolome R Celli, Peter M A Calverley, Stephen I Rennard, et al.
The European Respiratory Journal|April 4, 2014
Disease progression in young patients with COPD: rethinking the Fletcher and Peto modelPablo Sanchez-Salcedo, Miguel Divo, Ciro Casanova, et al.
The New England Journal of Medicine|September 9, 2014
Withdrawal of inhaled glucocorticoids and exacerbations of COPDHelgo Magnussen, Bernd Disse, Roberto Rodriguez-Roisin, et al.
The Lancet. Respiratory Medicine|April 13, 2016
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trialHenrik Watz, Kay Tetzlaff, Emiel F M Wouters, et al.
Respiratory Research|September 3, 2016
Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPDLeonardo M Fabbri, Edward M Kerwin, Selwyn Spangenthal, et al.
ERJ Open Research|October 13, 2016
The inflammasome pathway in stable COPD and acute exacerbationsRosa Faner, Patricia Sobradillo, Aina Noguera, et al.
Respiratory Medicine|November 8, 2016
A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPDDonald P Tashkin, Fernando J Martinez, Roberto Rodriguez-Roisin, et al.
Respiratory Medicine|July 23, 2017
Corrigendum to "A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD" [Respir. Med. 120 November 2016 16-24]Donald P Tashkin, Fernando J Martinez, Roberto Rodriguez-Roisin, et al.
American Journal of Respiratory and Critical Care Medicine|August 11, 2012
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryJørgen Vestbo, Suzanne S Hurd, Alvar G Agustí, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
American Journal of Respiratory and Critical Care Medicine|January 7, 2016
Network Analysis of Lung Transcriptomics Reveals a Distinct B-Cell Signature in EmphysemaRosa Faner, Tamara Cruz, Teresa Casserras, et al.
Respiratory Medicine|November 18, 2005
Proposal for a multidimensional staging system for chronic obstructive pulmonary diseaseBartolome R Celli, Peter M A Calverley, Stephen I Rennard, et al.
The European Respiratory Journal|April 4, 2014
Disease progression in young patients with COPD: rethinking the Fletcher and Peto modelPablo Sanchez-Salcedo, Miguel Divo, Ciro Casanova, et al.
The New England Journal of Medicine|September 9, 2014
Withdrawal of inhaled glucocorticoids and exacerbations of COPDHelgo Magnussen, Bernd Disse, Roberto Rodriguez-Roisin, et al.
The Lancet. Respiratory Medicine|April 13, 2016
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trialHenrik Watz, Kay Tetzlaff, Emiel F M Wouters, et al.
Respiratory Research|September 3, 2016
Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPDLeonardo M Fabbri, Edward M Kerwin, Selwyn Spangenthal, et al.
ERJ Open Research|October 13, 2016
The inflammasome pathway in stable COPD and acute exacerbationsRosa Faner, Patricia Sobradillo, Aina Noguera, et al.
Respiratory Medicine|November 8, 2016
A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPDDonald P Tashkin, Fernando J Martinez, Roberto Rodriguez-Roisin, et al.
Respiratory Medicine|July 23, 2017
Corrigendum to "A multicenter, randomized, double-blind dose-ranging study of glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler compared to the monocomponents and open-label tiotropium dry powder inhaler in patients with moderate-to-severe COPD" [Respir. Med. 120 November 2016 16-24]Donald P Tashkin, Fernando J Martinez, Roberto Rodriguez-Roisin, et al.
American Journal of Respiratory and Critical Care Medicine|August 11, 2012
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryJørgen Vestbo, Suzanne S Hurd, Alvar G Agustí, et al.
Pageof 5